Navigation Links
H. Lee Moffitt Cancer Center & Research Institute Selects Mariana Bugallo-Muros as Chief Human Resources Officer
Date:4/29/2015

Kansas City, Missouri (PRWEB) April 29, 2015

MSA Executive Search, an INTEGRATED company dedicated exclusively to healthcare executive search, announced today that Mariana Bugallo-Muros was selected as the Chief Human Resources Officer of H. Lee Moffitt Cancer Center and Research Institute (Moffitt) in Tampa, Florida, following a national search. Bugallo-Muros is expected to start in early June, succeeding Joanne Olson, who retired in March.

According to a press announcement released by Moffitt, “Mariana Bugallo-Muros comes to Moffitt from Partners HealthCare in Boston, Massachusetts, where she served 18 years in Corporate Human Resources leadership positions, most recently as Vice President. Partners includes the Massachusetts General Hospital, Brigham & Women’s Hospital and the Dana Farber Cancer Institute. Bugallo-Muros’s experience in a $7 billion academic integrated delivery system with over 60,000 employees, where she drove efforts to bind the organization’s culture and raise its performance, as well as leading innovative talent acquisition initiatives , will add great value to Moffitt Cancer Center & Research Institute.”

Bugallo-Muros holds a Bachelor’s degree in Business and a Master of Science degree in Management. Jane Groves, MSA Executive Search Executive Vice President, who led the search, states, “From Mariana’s very first inquiry regarding the Moffitt opportunity, she was drawn to the compelling mission of the Cancer Center and the comprehensiveness of the organization serving patient care, education and research.”

“This is an opportunity for me to bring my skills, experience and passion for human resources to a high- performing Moffitt leadership team with a clear vision for the future” Bugallo-Muros says, “I consider it a privilege to join Moffitt, and I look forward to getting started.”

“It has been our pleasure to work with Moffitt Cancer Center over the last five years in bringing key leaders into the organization. This CHRO search was especially rewarding for us, as the retiring executive was also an MSA placement,” says Roger Samuel, FACHE, MSA Executive Vice President & Practice Leader.

About MSA Executive Search
MSA has been a respected name in healthcare executive search for more than 30 years. As an INTEGRATED Healthcare Strategies company, MSA Executive Search offers our clients a comprehensive range of leadership placement solutions. Because we work exclusively within the healthcare industry, MSA understands the needs of hospital and health systems across the spectrum of size of revenues, independent or system affiliates. Our database of thousands of healthcare leaders and our exclusive, in-depth process to selected mission-critical key leaders has ensured that our clients find the right fit… the first time… for the long term.

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in the Southeast and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer since 1999. With more than 4,500 employees, Moffitt has an economic impact on the state of nearly $1.6 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.

Read the full story at http://www.prweb.com/releases/2015/04/prweb12684391.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Moffitt researchers help lead efforts to find new genetic links to prostate cancer
2. North Carolina Representative Tim Moffitt Visits Aeroflow Healthcare
3. Industry Leaders Rob and Tiffanie Moffitt Join mynt
4. Moffitt researchers develop new way to combat drug resistance for melanoma patients
5. Moffitt study shows utilizing genetic health care professional reduces unnecessary testing
6. Moffitt researchers develop process to help personalize treatment for lung cancer patients
7. Ohio State and Moffitt form worlds largest cancer research collaboration for big data
8. Moffitt Cancer Center instrumental in new clinical guidelines for cancer-related fatigue
9. Moffitt Cancer Centers phase 3 study may be game-changer for acute myeloid leukemia
10. Moffitt Cancer Center begins Phase I clinical trial of new immunotherapy
11. Moffitt instrumental in FDA approval of revolutionary 2-drug combo to treat advanced melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... ... its executive team as the President of its HealthBI division. McFarland will ... and contact centers. , “Scott is a utility player who balances his ...
(Date:9/19/2017)... ... September 19, 2017 , ... MelaKids, a Laredo-based company, has introduced a ... When we’re born, Nature gives us a full supply of melanin – in the ... lose this natural glare-reducing pigment; however, around the age of thirty, we develop a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... the present, Mirixa Corporation recently unveiled the MirixaPro 6.0 platform. As the ... how medication management services are delivered. Based on industry research and market ...
(Date:9/19/2017)... ... September 19, 2017 , ... Back Pain Centers of ... back pain with a reputable physician in their area, announces the addition of ... as Nevada Spine Clinic was founded by board-certified spine surgeon, Jaswinder Grover, M.D. ...
(Date:9/19/2017)... ... 2017 , ... The ISO 9001 standard sets out the requirements for a ... and improve customer satisfaction. ISO 9001:2015 was released in 2015 and certified organizations have ... September 2018. , As described in this white paper , ISO ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
(Date:9/9/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... lasmiditan, an investigational, oral, first-in-class molecule for the acute ... to placebo in the Phase 3 SPARTAN study. Detailed ... of the International Headache Society (IHC) in ... demonstrate lasmiditan,s potential to reduce pain and provide freedom ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
Breaking Medicine Technology: